Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis

被引:123
作者
Kowalska, M. Anna [1 ]
Rauova, Lubica
Poncz, Mortimer
机构
[1] Childrens Hosp Philadelphia, Div Pediat, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
HEPARIN-INDUCED THROMBOCYTOPENIA; ACTIVATED PROTEIN-C; LOW-DENSITY-LIPOPROTEIN; HUMAN MONOCYTES; CELL-SURFACE; IN-VIVO; THERAPEUTIC IMPLICATIONS; REGULATED EXPRESSION; ANTIGENIC COMPLEXES; TISSUE FACTOR;
D O I
10.1016/j.thromres.2009.11.023
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Chemokines are a family of small proteins that have significant roles in inflammation, angiogenesis and cellular homing. Since inflammation and hemostasis/thrombosis have multiple overlapping roles and pathways, one could expect that some chemokines would also have biologically significant roles in hemostasis/thrombosis as well. This would especially be true for chemokines that are localized solely or predominantly within platelets and released in large amounts at sites of platelet activation such as platelet factor 4 (PF4, CXCL4) and its closely related chemokine, platelet basic protein (PBP, CXCL7). Our group and others have clearly demonstrated an in vivo role for PF4 in hemostasis/thrombosis, but not for PBP, which in contrast has clear proinflammatory properties. This review will focus on PF4 and its potential roles in hemostasis/thrombosis and the underlying pathways by which PF4 may be especially important in such pathologic thrombotic states as heparin-induced thrombocytopenia (HIT) and septic shock. (C) 2009 Elsevier Ltd. All rights reserved.
引用
收藏
页码:292 / 296
页数:5
相关论文
共 57 条
[1]  
AMIRAL J, 1995, THROMB HAEMOSTASIS, V73, P21
[2]   Antibodies from patients with heparin-induced thrombocytopenia stimulate monocytic cells to express tissue factor and secrete interleukin-8 [J].
Arepally, GM ;
Mayer, IM .
BLOOD, 2001, 98 (04) :1252-1254
[3]  
Arepally Gowthami, 2002, Autoimmunity Reviews, V1, P125, DOI 10.1016/S1568-9972(02)00031-9
[4]   Chemokines and leukocyte traffic [J].
Baggiolini, M .
NATURE, 1998, 392 (6676) :565-568
[5]   REVERSAL OF HEPARIN ANTICOAGULATION BY RECOMBINANT PLATELET FACTOR-4 AND PROTAMINE SULFATE IN BABOONS DURING CARDIOPULMONARY BYPASS [J].
BERNABEI, A ;
GIKAKIS, N ;
MAIONE, TE ;
KOWALSKA, MA ;
YAN, Z ;
NIEWIAROWSKI, S ;
EDMUNDS, LH .
JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 1995, 109 (04) :765-771
[6]   Platelet-derived CXC chemokines: old players in new games [J].
Brandt, E ;
Ludwig, A ;
Petersen, F ;
Flad, HD .
IMMUNOLOGICAL REVIEWS, 2000, 177 :204-216
[7]   INTERACTION OF PLATELET FACTOR-4 WITH HUMAN-PLATELETS [J].
CAPITANIO, AM ;
NIEWIAROWSKI, S ;
RUCINSKI, B ;
TUSZYNSKI, GP ;
CIERNIEWSKI, CS ;
HERSHOCK, D ;
KORNECKI, E .
BIOCHIMICA ET BIOPHYSICA ACTA, 1985, 839 (02) :161-173
[8]   PLASMA-LEVELS OF PLATELET FACTOR-4 MEASURED BY RADIOIMMUNOASSAY [J].
CHESTERMAN, CN ;
MCGREADY, JR ;
DOYLE, DJ ;
MORGAN, FJ .
BRITISH JOURNAL OF HAEMATOLOGY, 1978, 40 (03) :489-500
[9]   HEPARIN-INDUCED THROMBOCYTOPENIA - EFFECTS OF RABBIT IGG, AND ITS FAB AND FC FRAGMENTS ON ANTIBODY-HEPARIN-PLATELET INTERACTION [J].
CHONG, BH ;
CASTALDI, PA ;
BERNDT, MC .
THROMBOSIS RESEARCH, 1989, 55 (02) :291-295
[10]   HEPARIN-ASSOCIATED THROMBOCYTOPENIA [J].
CINES, DB ;
KAYWIN, P ;
BINA, M ;
TOMASKI, A ;
SCHREIBER, AD .
NEW ENGLAND JOURNAL OF MEDICINE, 1980, 303 (14) :788-795